Exploring the Therapeutic Role of Physical Activity in Psychotic Disorders: Cognitive, Somatic, and Mental Health Impacts

Exploring the Therapeutic Role of Physical Activity in Psychotic Disorders: Cognitive, Somatic, and Mental Health Impacts

Introduction and Purpose: Psychotic disorders, such as schizophrenia, significantly affect both physical and mental health, often leading to a reduced quality of life. These conditions are commonly associated with somatic symptoms, fatigue, and impaired psychosocial functioning. This review aim...

Full description

Saved in:

Bibliographic Details
Main Authors:	Klaudia Fikas, Kamil Chwaliszewski, Dorota Waz, Michał Mazur, Jakub Szarłowicz, Zofia Goliszek, Karolina Łucja Sobek, Wiktoria Tabin-Barczak, Aldona Sokołowska, Sebastian Samuła
Format:	Article
Language:	English
Published:	Nicolaus Copernicus University in Toruń 2025-01-01
Series:	Quality in Sport
Subjects:	schizophrenia psychotic disorders physical activity psychosocial well-being cognitive functioning mental health
Online Access:	https://apcz.umk.pl/QS/article/view/57744
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrumResearch in context
by: Thuy-Dung Nguyen, et al.
Published: (2025-02-01)

Acute and transient psychotic disorders: A review of Indian research
by: Sandeep Grover, et al.
Published: (2023-09-01)

Dissociative psychosis or dissociative schizophrenia? Comparison of two phenomena
by: Mahir Akbudak, et al.
Published: (2025-01-01)

Editorial: Markers of clinical significance and treatment-seeking of psychotic experiences in non-clinical populations: potential resilience & risk factors
by: Suzanne Ho-wai So, et al.
Published: (2025-02-01)

Zipper Pattern: An Investigation into Psychotic Criminal Detection Using EEG Signals
by: Gulay Tasci, et al.
Published: (2025-01-01)

Existential concerns among young adults with psychotic vulnerability in mental health care: a qualitative study in the Netherlands
by: Marlous L. D. de Vries, et al.
Published: (2025-02-01)

Dutch Validation of the Self-Evaluation of Negative Symptoms Scale (SNS)
by: Tim van Brouwershaven, et al.
Published: (2024-12-01)

Association between fasting blood glucose and psychotic symptoms in Chinese patients with first-episode drug-naïve major depressive disorder
by: Xingzhi Xia, et al.
Published: (2025-01-01)

Effectiveness of Caregiver Intervention for Improving Medication Adherence on Level of Medication Adherence and Attitude toward Medications among Nonadherent Patients with Mental Illness
by: Simrat Kaur, et al.
Published: (2023-12-01)

A proof-of-concept analysis of data from the first NHS clinic for young adults with comorbid cannabis use and psychotic disorders
by: Marta Di Forti, et al.
Published: (2025-01-01)

Somatic symptoms in schizophrenia: Association with socio-demographic and clinical characteristics, disability and quality of life
by: Mamta Sood, et al.
Published: (2023-07-01)

A cognitive model of perceptual anomalies: The role of source monitoring, top-down influence and inhibitory processes for hallucinations in schizophrenia spectrum disorders and hallucinatory-like experiences in the general population
by: Adrianna Aleksandrowicz, et al.
Published: (2025-04-01)

Psikoz Olgularina Tedavi Uyumuna Yonelik Bir Terapi Programi Uygulanmasi
by: Ece Yazla, et al.
Published: (2019-08-01)

Intervention Programmes for First-Episode Psychosis: A Scoping Review
by: Marta Gouveia, et al.
Published: (2025-01-01)

Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative study
by: Soumitra Ghosh, et al.
Published: (2023-09-01)

Subjective cognition in schizophrenia and bipolar disorder: Investigation of group differences and associations with objective cognition and clinical characteristics using a novel measure of subjective cognition
by: Kristoffer Grimstad, et al.
Published: (2025-06-01)

Schizophrenia and Nicotine - A Bittersweet Psychiatric Story
by: Satrajit Ghosal, et al.
Published: (2025-01-01)

The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital
by: Indah Kurnia Utami, et al.
Published: (2024-11-01)

Psychosocial well-being index and sick leave in the workplace: a structural equation modeling of Wittyfit data
by: Rémi Colin-Chevalier, et al.
Published: (2025-01-01)

GREG HEFFLEY’S ROLE CONFUSION IN THE DIARY OF A WIMPY KID (2007): A PSYCHOSOCIAL ANALYSIS
by: Heri Dwi Santoso, et al.
Published: (2023-05-01)

Medication nonadherence and its associated factors in psychiatric patients in India: A systematic review and meta-analysis
by: Parthasarathy Ramamurthy, et al.
Published: (2023-05-01)

The profile of long-stay patients in a psychiatric hospital in KwaZulu-Natal, South Africa
by: Siziphiwe Y. Myeni, et al.
Published: (2025-01-01)

Association between treatment resistance and cognitive function in schizophrenia
by: Jiaqian Sun, et al.
Published: (2024-10-01)

Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia
by: Mulualem Kelebie, et al.
Published: (2025-02-01)

The Validity and Reliability of the Turkish version of Knowledge About Schizophrenia Questionnaire (KASQ)
by: Sevgi Dicle Gorkem Atalan, et al.
Published: (2018-04-01)

Faktor-Faktor yang Mempengaruhi Kepatuhan Minum Obat Pada Pasien Skizofrenia
by: Randy Refnandes, et al.
Published: (2024-12-01)

Penerapan Komunikasi Terapeutik Pada Pasien Skizofrenia Dalam Mengontrol Halusinasi Di RS Jiwa Menur Surabaya
by: Yosi Apriliani, et al.
Published: (2020-10-01)

Analisis Faktor-Faktor Yang Berhubungan dengan Kekambuhan pada Skizoprenia
by: Dewi Eka Putri, et al.
Published: (2020-10-01)

Quality of life in persons with schizophrenia
by: Zack Cernovsky
Published: (2017-03-01)

Gratitude in the recovery process: perspectives of women and men with schizophrenia
by: Iwona Michalczuk, et al.
Published: (2024-11-01)

Ferroptosis as a potential connection between schizophrenia and metabolic dysfunction-associated steatotic liver disease – a narrative review
by: Jakub Rogalski, et al.
Published: (2024-09-01)

Schizophasia and Cognitive Impairment in Schizophrenia: A Literature Review
by: Sylwia Niedźwiadek, et al.
Published: (2024-12-01)

Evaluation of a Deep Learning Model for Automatic Detection of Schizophrenia Using EEG Signals
by: Swetha Padmavathi Polisetty, et al.
Published: (2024-06-01)

Inductive Reasoning in Patients with Paranoid Type Schizophrenia
by: Mehmet Emrah Karadere, et al.
Published: (2017-08-01)

The Management of Social Phobia Ýn Residual-Type Schizophrenia with Cognitive Behavioral Therapy
by: Elif Þimþek Kaygusuz, et al.
Published: (2015-04-01)

Switching antipsychotics: Results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders
by: Bole Cvetka Bačar, et al.
Published: (2017-03-01)

Comparative effectiveness of aripiprazole and olanzapine on neurocognitive profile of patients with schizophrenia
by: Sanya Sharma, et al.
Published: (2023-10-01)

Development and validation of a recurrence risk prediction model for elderly schizophrenia patients
by: Biqi Zu, et al.
Published: (2025-01-01)

Lack of Clinically Meaningful Effect of Cariprazine on the Pharmacokinetics of a Combined Oral Contraceptive
by: Márta Erzsébet Rosa, et al.
Published: (2024-12-01)

Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds
by: Letizia Biso, et al.
Published: (2025-01-01)